- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01917292
Impact of Periodontal Intervention on Vascular Dysfunction
Periodontal Intervention Improves Vascular Function Among Chinese Prehypertensive Adults With Periodontitis
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Periodontitis is one of the low-grade chronic diseases, and it is the principal cause of tooth loss among middle-aged and elderly. Recently, epidemiological data indicate that patients with periodontitis are associated with increases in blood pressure levels and hypertension prevalence. Furthermore, studies from cross-sectional investigations demonstrate that hypertensive patients with periodontitis may enhance the risk and degree of vascular damage. Therefore, periodontal therapy is a novel therapeutic strategy to prevent the occurrence of BP elevation and retard the development vascular injury.
The term "prehypertension" indicates those with BPs ranging from 120 to 139 mm Hg systolic and/or 80 to 89 mm Hg diastolic blood pressure. Accumulating evidence suggests that subjects with prehypertension is associated with higher incidence of atherosclerotic vascular disease. However, until now there are no available data to investigate the influence of periodontitis on prehypertension and whether periodontal intervention may reduce the BP rise in subjects with prehypertension and improve the vascular function. We hypothesized that periodontitis leads to elevation in BP and periodontal therapy improves vascular function in subjects with prehypertension. To address these assumptions, The present study is designed to study the effect of periodontal intervention on blood pressure and vascular function and inflammatory biomarkers among Chinese prehypertensive adults with moderate to severe periodontal disease, and determine whether intensive periodontal therapy improves these measures over a 6-month follow-up period.
Studietype
Inschrijving (Werkelijk)
Fase
- Fase 3
Contacten en locaties
Studie Locaties
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510080
- The First Affiliated Hospital, Sun Yat-sen University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Subjects must be 18 years of age or older
- Moderate to severe generalized periodontitis(probing pocket depths of >6 mm and Marginal alveolar bone loss of >30%) with 50% or more of their teeth affected
- Have at least 16 natural teeth excluding third molars
- BPs ranging from 120 to 139 mm Hg systolic and/or 80 to 89 mm Hg diastolic blood pressure
- Provide informed consent and willingness to cooperate with the study protocol
Exclusion Criteria:
- History of antibiotic use in the previous three months
- Pregnant or lactating females
- Systemic diseases such as diabetes, HIV/AIDS, liver disease, chronic renal failure, tuberculosis, and autoimmune diseases
- Medical history of cardiovascular disease: Acute myocardial infarct, stable angina, unstable angina, heart failure, atrial fibrillation, atrioventricular blockade, peripheral vascular disease, cerebrovascular accident, hypertension
- Patients who received periodontal treatment within the last 6 months
- Patients who require antibiotic prophylaxis before examination or treatment
- Patients with mental retardation and dementia
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Ander: Periodontal care
|
|
Experimenteel: One-Stage Full-Mouth Disinfection
|
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
Change from Baseline in the Number of Endothelial Microparticle at 6 months
Tijdsspanne: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Change from Baseline in the Blood Pressure at 6 months
Tijdsspanne: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change in Brachia-ankle Pulse Wave Velocity(baPWV)
Tijdsspanne: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
|
Changes in high-sensitivity C-Reactive Protein(hs-CRP) and Interleukin-6(IL-6)
Tijdsspanne: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Compare the changes of traditional inflammatory biomarkers:hs-CRP and IL-6 over a 6-month follow-up period.
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Expression of the Long non-protein-coding RNA(lncRNA) and microRNA
Tijdsspanne: baseline
|
baseline
|
|
Changes in Malondialdehyde(MDA) and Superoxide Dismutase(SOD)
Tijdsspanne: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
|
Change in Periodontal Inflamed Surface Area(PISA)
Tijdsspanne: Baseline; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Bleeding on probing(BOP), clinical attachment loss (CAL) and gingival recession(GR) are measured to calculate the PISA.The PISA reflects the surface area of bleeding pocket epithelium in square millimetres.
|
Baseline; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Change in Endothelium-dependent Brachial Artery Flow-mediated Dilation(FMD)
Tijdsspanne: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Medewerkers en onderzoekers
Onderzoekers
- Studie directeur: Jun Ying Yang, Master, First Affiliated Hospital, Sun Yat-Sen University
- Studie stoel: Jun Tao, M.D.,phD., First Affiliated Hospital, Sun Yat-Sen University
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 20130718emp
- 31270992 (Register-ID: National Natural Science Foundation of China)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Periodontal care
-
Nexcella Inc.Nog niet aan het wervenLichte keten (AL) amyloïdoseVerenigde Staten
-
Second Affiliated Hospital, School of Medicine,...WervingRecidiverend en refractair B-cellymfoomChina
-
Hebei Senlang Biotechnology Inc., Ltd.WervingLymfoom | Multipel myeloom | Acute lymfatische leukemieChina
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy,...IngetrokkenAcute lymfatische leukemie | Non-Hodgkin lymfoomVerenigde Staten
-
Nanjing IASO Biotechnology Co., Ltd.Ruijin HospitalWervingPlasmacelleukemie | Recidiverend/refractair multipel myeloomChina
-
University of California, San FranciscoIngetrokkenLymfoom | Leukemie | Plasmaceldyscrasie
-
Southwest Hospital, ChinaOnbekendLymfoom, grote B-cel, diffuusChina
-
Fuda Cancer Hospital, GuangzhouIngetrokkenCAR-T-celimmunotherapie | Glioom van de hersenen
-
Technische Universität DresdenGerman Cancer Research CenterWervingNeoplasmata | Multipel myeloom bij terugval | Multipel myeloom, refractair | Recidiverend diffuus grootcellig B-cellymfoom (DLBCL) | Refractair diffuus grootcellig B-cellymfoom (DLBCL)Duitsland
-
Hangzhou Cheetah Cell Therapeutics Co., LtdBeëindigdVeiligheid en doeltreffendheidChina